Fig. 6From: Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatmentPTH and RANKL can protect and expand the resident HSC pool during cytotoxic chemotherapy. a Measurement of the HSC content of the bone marrow in the CTL, G and PTH groups by CRA at 16 weeks (n = 6 each group). b Measurement of the HSC content of the PB of mice in the CTL, G, P + G, P + R and P + R + G groups by CRA at 16 weeks (n = 6–8 each group)Back to article page